1,246
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Interleukin-25 enhances humoral immune responses caused by the rabies virus

, , , , , , & show all
Pages 1446-1454 | Received 28 Mar 2022, Accepted 18 Aug 2022, Published online: 26 Aug 2022

References

  • Fu ZF Rabies and rabies research: past, present and future. Vaccine. 1997;15:S20–S24.
  • Schnell MJ, Mebatsion T, Conzelmann KK Infectious rabies viruses from cloned cDNA. Embo J. 1994;13(18):4195–4203.
  • Luo J, Zhang B, Wu Y, et al. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Vaccine. 2017;35(6):938–944. DOI:10.1016/j.vaccine.2016.12.069
  • Zhang S, Hao M, Feng N, et al. Genetically modified rabies virus vector-based rift valley fever virus vaccine is safe and induces efficacious immune responses in mice. Viruses. 2019;11(10):919. DOI:10.3390/v11100919
  • Kurup D, Malherbe DC, Wirblich C, et al. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. PLoS Pathog. 2021;17(3):e1009383. DOI:10.1371/journal.ppat.1009383
  • Wang H, Jin H, Feng N, et al. Using rabies virus vaccine strain SRV9 as viral vector to express exogenous gene. Virus Genes. 2015;50(2):299–302. DOI:10.1007/s11262-014-1160-y
  • Wang Z, Liang Q, Zhang Y, et al. An optimized HMGB1 expressed by recombinant rabies virus enhances immunogenicity through activation of dendritic cells in mice. Oncotarget. 2017;8(48):83539–83554. DOI:10.18632/oncotarget.18368
  • Lee J, Ho WH, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17rh1. J Biol Chem. 2001;276(2):1660–1664. DOI:10.1074/jbc.M008289200
  • Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149–162.
  • Kim MR, Manoukian R, Yeh R, et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood. 2002;100(7):2330–2340. DOI:10.1182/blood-2002-01-0012
  • Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203(4):1105–1116. DOI:10.1084/jem.20051615
  • Owyang AM, Zaph C, Wilson EH, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med. 2006;203(4):843–849. DOI:10.1084/jem.20051496
  • Luo J, Zhao J, Tian Q, et al. A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro. Virus Genes. 2016;52(3):379–387. DOI:10.1007/s11262-016-1313-2
  • Inoue K, Shoji Y, Kurane I, et al. An improved method for recovering rabies virus from cloned cDNA. J Virol Methods. 2003;107(2):229–236. DOI:10.1016/S0166-0934(02)00249-5
  • Luo J, Zhang Y, Zhang Q, et al. The deoptimization of rabies virus matrix protein impacts viral transcription and replication. Viruses. 2019;12(1): DOI:10.3390/v12010004
  • Luo J, Zhang Y, Wang Y, et al. Rhabdovirus infection is dependent on Serine/Threonine kinase AP2-associated kinase 1. Life (Basel). 2020;10(9): DOI:10.3390/life10090170
  • Luo J, Zhang B, Lyu Z, et al. Single amino acid change at position 255 in rabies virus glycoprotein decreases viral pathogenicity. Faseb J. 2020;34(7):9650–9663. DOI:10.1096/fj.201902577R
  • Cliquet F, Aubert M, Sagne L Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods. 1998;212(1):79–87.
  • Mebatsion T, Schnell MJ, Cox JH, et al. Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A. 1996;93(14):7310–7314.
  • Ceccaldi PE, Fayet J, Conzelmann KK, et al. Infection characteristics of rabies virus variants with deletion or insertion in the pseudogene sequence. J Neurovirol. 1998;4(1):115–119.
  • Schnell MJ, Foley HD, Siler CA, et al. Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc Natl Acad Sci U S A. 2000;97(7):3544–3549. DOI:10.1073/pnas.97.7.3544
  • Wang Y, Tian Q, Xu X, et al. Recombinant rabies virus expressing IFNalpha1 enhanced immune responses resulting in its attenuation and stronger immunogenicity. Virology. 2014;468-470:621–630.
  • Mcgettigan JP, Pomerantz RJ, Siler CA, et al. Second-Generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. J Virol. 2003;77(1):237–244. DOI:10.1128/JVI.77.1.237-244.2003
  • Zhang Y, Yang J, Li M, et al. A recombinant rabies virus expressing fms-like tyrosine kinase 3 ligand (Flt3l) induces enhanced immunogenicity in mice. Virol Sin. 2019;34(6):662–672. DOI:10.1007/s12250-019-00144-x
  • Xue X, Zheng X, Liang H, et al. Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test. Viruses. 2014;6(4):1578–1589. DOI:10.3390/v6041578
  • Zhou M, Wang L, Zhou S, et al. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs. Oncotarget. 2015;6(36):38504–38516. DOI:10.18632/oncotarget.5904
  • Chen T, Zhang Y, Wang Z, et al. Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice. Virol Sin. 2017;32(4):317–327. DOI:10.1007/s12250-017-4036-1
  • Zhang Y, Zhou M, Wang Z, et al. Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal centre B cells. J Gen Virol. 2016;97(12):3154–3160. DOI:10.1099/jgv.0.000646
  • Zhao L, Toriumi H, Wang H, et al. Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J Virol. 2010;84(18):9642–9648. DOI:10.1128/JVI.00326-10
  • Koraka P, Bosch BJ, Cox M, et al. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Vaccine. 2014;32(36):4644–4650. DOI:10.1016/j.vaccine.2014.06.058
  • Liu X, Yang Y, Sun Z, et al. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. PLoS One. 2014;9(2):e87105. DOI:10.1371/journal.pone.0087105
  • Wang C, Liu Q, Chen F, et al. IL-25 promotes Th2 immunity responses in asthmatic mice via nuocytes activation. PLoS One. 2016;11(9):e162393.
  • Wang H, Jiang Y, Wang H, et al. IL-25 promotes Th2-type reactions and correlates with disease severity in the pathogenesis of oral lichen planus. Arch Oral Biol. 2019;98:115–121.
  • George JA, Kim SB, Choi JY, et al. Tlr2/myd88 pathway-dependent regulation of dendritic cells by dengue virus promotes antibody-dependent enhancement via Th2-biased immunity. Oncotarget. 2017;8(62):106050–106070. DOI:10.18632/oncotarget.22525
  • Spellberg B, Edwards JJ Type 1/type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32(1):76–102.